CTLA-4 (CD152)-induced signaling pathways as regulators of CD8+ T lymphocytes (B14)
CTLA-4 (CD152)-induced signaling pathways as regulators of CD8+ T lymphocytes (B14)
批准号:
163824312
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Collaborative Research Centres
财政年份:
2010
资助国家:
德国
项目状态:
已结题
起止时间:
2009-12-31 至 2020-12-31
中文摘要
为了防止免疫病理,CD8+ T细胞的分化受到抑制受体(如CTLA-4)的严格控制。项目B14与B16合作,通过iTRAQ质谱鉴定了CTLA-4下游的新型信号转导途径,将在第三个资助期进一步表征。在这方面,B14将细胞代谢的变化与T细胞功能的改变联系起来。ctla -4介导的TCF-1调控在记忆形成中的作用将在李斯特菌感染模型中与A05合作进行分析。此外,B14将与B08和B12合作,分析CTLA-4在共刺激和粘附的情况下对JAML的影响。
英文摘要
To prevent immunopathology, differentiation of CD8+ T cells is tightly controlled by inhibitory receptors such as CTLA-4. Project B14, in collaboration with B16, identified by iTRAQ mass spectrometry novel signal transduction pathways downstream of CTLA-4 that will be further characterized in the 3rd funding period. In this respect, B14 will connect changes in cellular metabolism with altered T cell functions. The role of CTLA-4-mediated TCF-1 regulation in memory formation will be analyzed in a Listeria infection model in collaboration with A05. Furthermore, B14 will analyze the impact of CTLA-4 on JAML in the context of co-stimulation and adhesion in collaboration with B08 and B12.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
FK506对肾移植受者Treg细胞负性共刺激信号分子-CD152、PD-1和BTLA的免疫耐受调节研究
-
批准号:30950010
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2009
-
负责人:石运莹
-
依托单位: